The ScholarGPS website collects information through the use of "cookies" or similar technologies in order to function more efficiently and analyze use of the website. You are free to restrict or block cookies as further explained in our Cookies Policy, however depending on the selection of your settings, the full features/functionality of the website may no longer be available.

Decline

Theravance Biopharma R&D IP, LLC

United States

Metrics Summary

Total Publications

Lifetime

298

Prior Five Years

186

Total Citations

Lifetime

1,383

Prior Five Years

654

Total Scholars

Lifetime

141

Prior Five Years

120

Non-academic Institutional Ranking

Global Overall (All Fields)

Worldwide

Lifetime

N/A

Prior Five Years

N/A

National Overall (All Fields)

United States

Lifetime

N/A

Prior Five Years

N/A

Institutional Rankings

Fields, Disciplines and Specialties

Lifetime

View

Prior Five Years

View

Evaluation Period:

		Global Specialty Lifetime
N/A	N/A	#1	Clinical pharmacy
		#5	Linezolid
		#9	Ciprofloxacin
		#10	Muscarinic acetylcholine receptor
		#17	Vancomycin
		#38	Receptor antagonist
		#74	Antimicrobial
		#82	Pharmacokinetics

		Global Specialty Prior Five Years
N/A	N/A	#5	Maintenance therapy
		#11	Ulcerative colitis
		#12	Tumor necrosis factor alpha

Publications and Citation History

Publications based on Fields

Scholars based on Fields

Publications based on Top 20 Disciplines

Scholars based on Top 20 Disciplines

Evaluation Period:

Highly Ranked Scholars™

Overall (All Fields)

Lifetime

Field

Lifetime

Discipline

Lifetime

Specialty

Lifetime

Top Scholars by Institution

Evaluation Period:

Highly Cited Publications

Lifetime